Biohaven Therapeutics Ltd.

Kleo Pharmaceuticals, Inc.

Anna Bunin

David Spiegel

Matthew Welsch

Douglas Manion

Lawrence G Iben

Luca Rastelli

Among other things, the present disclosure provides technologies comprising immune cells and antibody-recruiting molecules. In some embodiments, immune cells are memory-like natural killer cells. In some embodiments, provided technologies are particularly useful for treating a condition, disorder or disease like cancer. In some embodiments, provided technologies provide high efficacy. In some embodiments, provided technologies provide less or less severe side effects associated with natural killer cell therapy.

Combination therapy of arms and natural killer cells

Among other things, the present disclosure provides compounds, compositions thereof, and methods of using the same. In some embodiments, compounds of the present disclosure bind to Fc receptors, e.g., CD16a. In some embodiments, compounds of the present disclosure are useful for treating various conditions, disorders or diseases including cancer.

CD16a binding agents and uses thereof

CD16A binding agents and uses thereof

Growing community of inventors

Rego Park, NY, United States of America

Anna Bunin